Botulinum Toxin Injection Market
Global Botulinum Toxin Injection Market Size, Share & Trend Analysis by Application (Therapeutics and Aesthetics), by Type (Botulinum Toxin Type A, and Botulinum Toxin Type B), and by End-User (Hospitals & Clinics, Specialty & Dermatology Clinics, and Others), Forecast 2022-2028 Update Available - Forecast 2024-2030
The global botulinum toxin injection market is anticipated to grow at a significant CAGR of 5.9% during the forecast period (2022-2028). Botulinum toxin is a drug made from a toxin that is produced by the bacterium clostridium botulinum and is used in small doses for the treatment of health problems such as temporary smoothing of facial wrinkles and improving appearance. The surge in the demand for facial aesthetics is anticipated as one of the factors which is driving the growth of the botulinum toxin injection market. Moreover, botulinum toxin is used to treat several age-related conditions such as forehead lines, glabellar lines and others. Hence, people above the age of 40 are expected to be prone to such signs of ageing. This botulinum toxin procedure is expected to gain more importance among the population aged between 40 -54 years, thereby augmenting the market growth.
Impact of COVID-19 on Global Botulinum Toxin Injection Market
Globally, the spread of the COVID-19 pandemic impacted the botulinum toxin injection market negatively in 2020. Various companies witnessed a decline from 9% to 30% in the sales of botulinum toxin products due to COVID-19. For instance, Allergan, a key player among the botox market reported the decline of 33.1% to 34.8% of revenue in 2020. In addition, imposition of lockdown and various restrictions at national level postponed the non-essential surgical and non-invasive procedures. According to the American Society of Plastic Surgeons (ASPS) reports, in 2020, the total number of Botox type A procedures declined from 5.04 million in 2019 to 4.40 million. Additionally, the market observed a decline of 12.7% in botox procedures across the globe.
Segmental Outlook
The global botulinum toxin injection market is segmented based on application, type and end-user. Based on the application, the market is sub-segmented into therapeutics and aesthetics. The therapeutic application includes cervical dystonia, blepharospasm, overactive bladder, chronic migraine, spasticity, and others. Based on the type, the market is sub-segmented into botulinum toxin type A and botulinum toxin type B. Further, based on the end-user, the market is augmented into hospitals & clinics, specialty & dermatology clinics, and others. Among the application, the aesthetic segment is anticipated to contribute in propelling the growth of the market over the forecast period owing to the increasing awareness towards the different types of cosmetic procedures catering to reduce the signs of ageing.
Global Botulinum Toxin Injection Market, by Type 2021 (%)
The Botulinum Type A Segment is Anticipated to Hold Prominent Share in the Global Botulinum Toxin Injection Market
Growing applications in the aesthetic and medical field along with the rise in interest of manufacturers to develop such products is anticipated to incline the market progression. Various botulinum toxin A products are commercially available in the market including Dysport and Botox. the products have been clinically proven to be effective and safe in long term with minimal side effects. For instance, according to the national clinical trial (NCT)registry, in 2021, more than 312 clinical trials took place related to botulinum toxin type A across different development phases. Thus incline in the demand for botulinum toxin type A is subsequently boosting the growth of the global botulinum toxin injection market.
Regional Outlook
The global botulinum toxin injection market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. The North American regional cognitive media market is expected to hold a prominent market share due to the presence of several key market players.
Global Botulinum Toxin Injection Growth, by Region 2021-2028
The North American region is estimated to Hold Major Share in Global Botulinum Toxin Injection Market
North America Botulinum toxin market is anticipated to propel the growth of the market over the forecast period owing to the availability of a variety of aesthetic procedures along with growing income. Also, in the US, rapid advancements in medical and aesthetic procedures have enabled market opportunities for several market players. Furthermore, advanced technologies have introduced a wide range of solutions and products to patients seeking medical assistance. Thus, due to technological advancement in aesthetic procedures, the North American region has contributed a considerable share in the growth of the global botulinum toxin injection market.
Market Players Outlook
The major companies serving the global botulinum toxin injection market is AbVie Inc. (Allergan PLC, Eisai co. ltd, Hugel Inc and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For Instance, in August 2021, Merz Therapeutics announced that the company received approval from the Russian Federal Service for surveillance in healthcare for the use of Xeomin, a neurotoxin for the symptomatic treatment of chronic sialorrhea due to neurodevelopmental disorders in children between 2 to 17 years of age.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global botulinum toxin injection market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Botulinum Toxin Injection market
• Recovery Scenario of Global Botulinum Toxin Injection market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. AbVie Inc. (Allergan PLC)
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Eisai co. Ltd.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Hugel Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Ipsen
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Medytox
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Botulinum Toxin Injection Market by Application
4.1.1. Therapeutics
4.1.1.1. Chronic Migraine
4.1.1.2. Spasticity
4.1.1.3. Overactive Bladder
4.1.1.4. Cervical Dystonia
4.1.1.5. Blepharospasm
4.1.2. Aesthetics
4.2. Global Botulinum Toxin Injection Market by Type
4.2.1. Botulinum Toxin Type A
4.2.2. Botulinum Toxin Type B
4.3 Global Botulinum Toxin Injection Market by End User
4.3.1 Hospital and clinics
4.3.2 Specialty and Dermatology Clinic
4.3.3 Others
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Abbott Laboratories
6.2. Abaxis
6.3. AjinoMoto Bio Pharma Services
6.4. Alembic Pharmaceuticals Ltd.
6.5. Amgen, Inc.
6.6. AstraZeneca PLC
6.7. Bristol Myers Squibb
6.8. Biogen Inc.
6.9. Bausch + Lomb
6.10. Celgene Corp.
6.11. C’Bon Cosmetics Co. Ltd.
6.12. EMS
6.13. Eli Lilly and Co.
6.14. Gilead Sciences, Inc.
6.15. Merz Pharma GmbH & Co. KGaA
6.16. Revance
6.17. F. Hoffmann-La Roche AG
6.18. Takeda Pharma Co.
6.19. Sanofi SA
1. GLOBAL BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
2. GLOBAL BOTULINUM TOXIN INJECTION FOR THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY THERAPEUTICS, 2021-2028 ($ MILLION)
4. GLOBAL BOTULINUM TOXIN INJECTION FOR CHRONIC MIGRAINE MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL BOTULINUM TOXIN INJECTION FOR SPASTICITY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL BOTULINUM TOXIN INJECTION FOR CERVICAL DYSTONIA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL BOTULINUM TOXIN INJECTION FOR OVERACTIVE BLADDER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL BOTULINUM TOXIN INJECTION FOR BLEPHAROSPASM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL BOTULINUM TOXIN INJECTION FOR AESTHETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10. GLOBAL BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
11. GLOBAL BOTULINUM TOXIN INJECTION TYPE A MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL BOTULINUM TOXIN INJECTION TYPE B MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13. GLOBAL BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
14. GLOBAL BOTULINUM TOXIN INJECTION IN HOSPITAL AND CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL BOTULINUM TOXIN INJECTION IN SPECIALITY AND DERMATOLOGY CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
17. NORTH AMERICAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. NORTH AMERICAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
19. NORTH AMERICAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
20. NORTH AMERICAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY END-USER CHANNEL, 2021-2028 ($ MILLION)
21. EUROPEAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
22. EUROPEAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
23. EUROPEAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
24. EUROPEAN BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
25. ASIA-PACIFIC BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION 2021-2028 ($ MILLION)
27. ASIA-PACIFIC BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
29. REST OF THE WORLD BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
30. REST OF THE WORLD BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
31. REST OF THE WORLD BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
32. REST OF THE WORLD BOTULINUM TOXIN INJECTION MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL BOTULINUM TOXIN INJECTION MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL BOTULINUM TOXIN INJECTION MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL BOTULINUM TOXIN INJECTION MARKET, 2021-2028 (%)
4. GLOBAL BOTULINUM TOXIN INJECTION MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
5. GLOBAL BOTULINUM TOXIN INJECTION FOR THERAPEUTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL BOTULINUM TOXIN INJECTION MARKET SHARE BY THERAPEUTUC, 2021 VS 2028 (%)
7. GLOBAL BOTULINUM TOXIN INJECTION FOR CHRONIC MIGRAINE MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8. GLOBAL BOTULINUM TOXIN INJECTION FOR SPASTICITY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL BOTULINUM TOXIN INJECTION FOR CERVICAL DYSTONIA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL BOTULINUM TOXIN INJECTION FOR OVERACTIVE BLADDER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. GLOBAL BOTULINUM TOXIN INJECTION FOR BLEPHAROSPASM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
12. GLOBAL BOTULINUM TOXIN INJECTION FOR AESTHETICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13. GLOBAL BOTULINUM TOXIN INJECTION MARKET SHARE BY TYPE, 2021 VS 2028 (%)
14. GLOBAL BOTULINUM TOXIN INJECTION TYPE A MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15. GLOBAL BOTULINUM TOXIN INJECTION TYPE B MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16. GLOBAL BOTULINUM TOXIN INJECTION MARKET SHARE BY END-USER, 2021 VS 2028 (%)
17. GLOBAL BOTULINUM TOXIN INJECTION IN HOSPITAL AND CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18. GLOBAL BOTULINUM TOXIN INJECTION IN SPECIALITY AND DERMATOLOGY CLINIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
19. GLOBAL BOTULINUM TOXIN INJECTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20. US BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
21. CANADA BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
22. UK BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
23. FRANCE BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
24. GERMANY BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
25. ITALY BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
26. SPAIN BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
27. REST OF EUROPE BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
28. INDIA BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
29. CHINA BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
30. JAPAN BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
31. SOUTH KOREA BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
32. REST OF ASIA-PACIFIC BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
33. REST OF THE WORLD BOTULINUM TOXIN INJECTION MARKET SIZE, 2021-2028 ($ MILLION)
